Literature DB >> 7691888

Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

J C Lapiere1, D T Woodley, M G Parente, T Iwasaki, K C Wynn, A M Christiano, J Uitto.   

Abstract

Epidermolysis bullosa acquisita (EBA) is an acquired blistering skin disease characterized by the presence of IgG autoantibodies that recognize type VII (anchoring fibril) collagen. In this study, we have mapped the antigenic epitopes within the type VII collagen alpha chain by Western immunoblotting analysis with sera from 19 patients with EBA, using bacterial collagenase- or pepsin-resistant portions of type VII collagen and a panel of 12 recombinant fusion proteins corresponding to approximately 80% of the primary sequence of the alpha 1 (VII) collagen polypeptide. These studies identified four major immunodominant epitopes localized within the amino-terminal, noncollagenous (NC-1) domain. In addition to EBA, sera from three patients with bullous systemic lupus erythematosus (BSLE) were tested. The pattern of epitopes recognized by these sera were similar to those noted with EBA, suggesting that the same epitopes could serve as autoantigens in both blistering conditions. In contrast, sera from healthy controls or from patients with unrelated blistering skin diseases did not react with type VII collagen epitopes. Collectively, the results indicate that the immunodominant epitopes in EBA and BSLE lie within the noncollagenous regions of type VII collagen. The precise role of the circulating autoantibodies in the pathogenesis of these blistering diseases remains to be elucidated. Conceivably, however, such antibodies could disrupt the assembly of type VII collagen into anchoring fibrils and/or interfere with their interactions with other extracellular matrix molecules within the cutaneous basement membrane zone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691888      PMCID: PMC288347          DOI: 10.1172/JCI116774

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.

Authors:  A S Paller; L L Queen; D T Woodley; W R Gammon; E J O'Keefe; R A Briggaman
Journal:  J Invest Dermatol       Date:  1985-03       Impact factor: 8.551

3.  Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.

Authors:  W R Gammon; A O Inman; C E Wheeler
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

4.  Epidermolysis bullosa acquisita--a pemphigoid-like disease.

Authors:  W R Gammon; R A Briggaman; D T Woodley; P W Heald; C E Wheeler
Journal:  J Am Acad Dermatol       Date:  1984-11       Impact factor: 11.527

5.  Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique.

Authors:  M J Tidman; R A Eady
Journal:  J Invest Dermatol       Date:  1985-05       Impact factor: 8.551

6.  Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.

Authors:  D T Woodley; R A Briggaman; E J O'Keefe; A O Inman; L L Queen; W R Gammon
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.

Authors:  W R Gammon; D T Woodley; K C Dole; R A Briggaman
Journal:  J Invest Dermatol       Date:  1985-06       Impact factor: 8.551

9.  Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients.

Authors:  C Nieboer; D M Boorsma; M J Woerdeman; G L Kalsbeek
Journal:  Br J Dermatol       Date:  1980-04       Impact factor: 9.302

10.  Type VII collagen is a major structural component of anchoring fibrils.

Authors:  L Y Sakai; D R Keene; N P Morris; R E Burgeson
Journal:  J Cell Biol       Date:  1986-10       Impact factor: 10.539

View more
  37 in total

1.  Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.

Authors:  K Gandhi; M Chen; S Aasi; J C Lapiere; D T Woodley; L S Chan
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

2.  [Vesicle, light hypersensitivity, mouth ulceration and arthralgia in a 40-year-old patient. Bullous systemic lupus erythematosus].

Authors:  A Kolb-Mäurer; S Herzog; C Sitaru; C Kneitz; D Zillikens; M Goebeler
Journal:  Hautarzt       Date:  2002-03       Impact factor: 0.751

Review 3.  Epidermolysis bullosa acquisita.

Authors:  Rishu Gupta; David T Woodley; Mei Chen
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

Review 4.  Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen.

Authors:  Mei Chen; Gene H Kim; Lori Prakash; David T Woodley
Journal:  Autoimmunity       Date:  2011-09-28       Impact factor: 2.815

Review 5.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 6.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

7.  Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells.

Authors:  L Chen; J D Peterson; W-Y Zheng; S-X Lin; L S Chan
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 8.  The diagnosis and treatment of autoimmune blistering skin diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Dtsch Arztebl Int       Date:  2011-06-10       Impact factor: 5.594

9.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

10.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases.

Authors:  K G Becker; R M Simon; J E Bailey-Wilson; B Freidlin; W E Biddison; H F McFarland; J M Trent
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.